Dimitrios T Boumpas - JoVE Visualize

Showing results (41-50 of 194) with videos related to

Pageof 20

Sort By:

Human Immunology|August 16, 2008

STAT4: a risk factor for type 1 diabetes?Maria I Zervou, Dimitrios Mamoulakis, Charalampos Panierakis, et al.

Journal of Leukocyte Biology|July 31, 2013

Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in miceIrene Kyrmizi, Marianna Ioannou, Maria Hatziapostolou, et al.

Lupus|December 9, 2022

Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center studyGeorgia-Savina Moysidou, Panagiotis Garantziotis, Dionysis Nikolopoulos, et al.

Blood|July 2, 2002

Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapyHelen A Papadaki, Heraklis D Kritikos, Vasilis Valatas, et al.

Lupus|September 28, 2022

Residual disease activity and treatment intensification in systemic lupus erythematosus: A cross-sectional study to quantify the need for new therapiesOurania Gioti, Katerina Chavatza, Myrto Nikoloudaki, et al.

Arthritis and Rheumatism|January 31, 2009

Increased expression of CD40 on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to Fas-mediated apoptosisKaterina Pyrovolaki, Irene Mavroudi, Prodromos Sidiropoulos, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2013

Programmed death-1 shapes memory phenotype CD8 T cell subsets in a cell-intrinsic mannerJoanna J Charlton, Ioannis Chatzidakis, Debbie Tsoukatou, et al.

Autoimmunity|March 10, 2017

Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responsesEleni Kontaki, Dimitrios T Boumpas, Maria Tzardi, et al.

RMD Open|July 24, 2020

Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendationsMyrto Kostopoulou, Antonis Fanouriakis, Kim Cheema, et al.

Autoimmunity Reviews|November 8, 2017

Can we withdraw immunosuppressants in patients with lupus nephritis in remission? An expert debateGabriella Moroni, Mariele Gatto, Francesca Raffiotta, et al.

Pageof 20

Showing results (41-50 of 194) with videos related to

Sort By:

Pageof 20

Human Immunology|August 16, 2008

STAT4: a risk factor for type 1 diabetes?Maria I Zervou, Dimitrios Mamoulakis, Charalampos Panierakis, et al.

Journal of Leukocyte Biology|July 31, 2013

Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in miceIrene Kyrmizi, Marianna Ioannou, Maria Hatziapostolou, et al.

Lupus|December 9, 2022

Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center studyGeorgia-Savina Moysidou, Panagiotis Garantziotis, Dionysis Nikolopoulos, et al.

Blood|July 2, 2002

Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapyHelen A Papadaki, Heraklis D Kritikos, Vasilis Valatas, et al.

Lupus|September 28, 2022

Residual disease activity and treatment intensification in systemic lupus erythematosus: A cross-sectional study to quantify the need for new therapiesOurania Gioti, Katerina Chavatza, Myrto Nikoloudaki, et al.

Arthritis and Rheumatism|January 31, 2009

Increased expression of CD40 on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to Fas-mediated apoptosisKaterina Pyrovolaki, Irene Mavroudi, Prodromos Sidiropoulos, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2013

Programmed death-1 shapes memory phenotype CD8 T cell subsets in a cell-intrinsic mannerJoanna J Charlton, Ioannis Chatzidakis, Debbie Tsoukatou, et al.

Autoimmunity|March 10, 2017

Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responsesEleni Kontaki, Dimitrios T Boumpas, Maria Tzardi, et al.

RMD Open|July 24, 2020

Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendationsMyrto Kostopoulou, Antonis Fanouriakis, Kim Cheema, et al.

Autoimmunity Reviews|November 8, 2017

Can we withdraw immunosuppressants in patients with lupus nephritis in remission? An expert debateGabriella Moroni, Mariele Gatto, Francesca Raffiotta, et al.

Pageof 20